Bank of America’s Oragenics OGEN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-37
| Closed | -$29 | – | 6536 |
|
|
2025
Q4 | $29 | Buy |
37
+1
| +3% | +$1 | ﹤0.01% | 7051 |
|
|
2025
Q3 | $47 | Sell |
36
-15,510
| -100% | -$19.6K | ﹤0.01% | 8021 |
|
|
2025
Q2 | $59.4K | Buy |
15,546
+15,539
| +221,986% | +$78.8K | ﹤0.01% | 6748 |
|
|
2025
Q1 | $44 | Hold |
7
| – | – | ﹤0.01% | 8005 |
|
|
2024
Q4 | $75 | Buy |
7
+2
| +40% | +$20 | ﹤0.01% | 7800 |
|
|
2024
Q3 | $59 | Hold |
5
| – | – | ﹤0.01% | 7813 |
|
|
2024
Q2 | $156 | Buy |
5
+1
| +25% | +$45 | ﹤0.01% | 7613 |
|
|
2024
Q1 | $163 | Hold |
4
| – | – | ﹤0.01% | 7361 |
|
|
2023
Q4 | $636 | Hold |
4
| – | – | ﹤0.01% | 7255 |
|
|
2023
Q3 | $336 | Hold |
4
| – | – | ﹤0.01% | 7358 |
|
|
2023
Q2 | $374 | Hold |
4
| – | – | ﹤0.01% | 7345 |
|
|
2023
Q1 | $375 | Hold |
4
| – | – | ﹤0.01% | 7387 |
|
|
2022
Q4 | $725 | Buy |
+4
| New | +$1.41K | ﹤0.01% | 7388 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 8615 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 8517 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 8304 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 7982 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 7672 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 7284 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 7423 |
|
|
2019
Q2 | – | Sell |
-11
| Closed | -$10.1K | – | 7341 |
|
|
2019
Q1 | $12K | Buy |
+11
| New | +$17.3K | ﹤0.01% | 6608 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 7291 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 7409 |
|
|
2018
Q2 | – | Hold |
0
| – | – | – | 7250 |
|
|
2018
Q1 | – | Hold |
0
| – | – | – | 7264 |
|
|
2017
Q4 | – | Hold |
0
| – | – | – | 7178 |
|
|
2017
Q3 | – | Hold |
0
| – | – | – | 6942 |
|
|
2017
Q2 | – | Hold |
0
| – | – | – | 6829 |
|
|
2017
Q1 | – | Hold |
0
| – | – | – | 6863 |
|
|
2016
Q4 | – | Hold |
0
| – | – | – | 6917 |
|
|
2016
Q3 | – | Hold |
0
| – | – | – | 6832 |
|
|
2016
Q2 | – | Hold |
0
| – | – | – | 6998 |
|
|
2016
Q1 | – | Hold |
0
| – | – | – | 6779 |
|
|
2015
Q4 | – | Hold |
0
| – | – | – | 7019 |
|
|
2015
Q3 | – | Hold |
0
| – | – | – | 6899 |
|
|
2015
Q2 | – | Hold |
0
| – | – | – | 7052 |
|
|
2015
Q1 | – | Sell |
-1
| Closed | -$17.5K | – | 6702 |
|
|
2014
Q4 | $11K | Hold |
1
| – | – | ﹤0.01% | 7021 |
|
|
2014
Q3 | $15K | Hold |
1
| – | – | ﹤0.01% | 7176 |
|
|
2014
Q2 | $23K | Hold |
1
| – | – | ﹤0.01% | 7109 |
|
|
2014
Q1 | $34K | Hold |
1
| – | – | ﹤0.01% | 6644 |
|
|
2013
Q4 | $33K | Hold |
1
| – | – | ﹤0.01% | 6806 |
|
|
2013
Q3 | $35K | Hold |
1
| – | – | ﹤0.01% | 6623 |
|
|
2013
Q2 | $37K | Buy |
+1
| New | +$56.6K | ﹤0.01% | 6726 |
|
Other funds holding OGEN
TSS
HF
VF
TRCT
AAS
SJIM
Bank of America's OGEN Position: Q1 2026 in Review
Bank of America sold out of Oragenics (OGEN) in Q1 2026, closing a stake of 37 shares — an estimated $29 sold.
Bank of America first reported a position in OGEN in Q2 2013 and held it in 21 quarters. The position peaked at $59.4K in Q2 2025. 20 funds tracked by Wall St. Rank hold OGEN as of Q1 2026.
- Bank of America reported no remaining Oragenics position as of Q1 2026 after selling out during the quarter.
- Bank of America sold 37 Oragenics shares in Q1 2026, an estimated $29.
- Bank of America first reported a position in Oragenics in Q2 2013 and held it in 21 quarters.
- Bank of America's Oragenics position peaked at $59.4K in Q2 2025.
- 20 funds tracked by Wall St. Rank held Oragenics as of Q1 2026.
Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.